France· FR:66105532
BYDUREON 2 mg, poudre et solvant pour suspension injectable à libération prolongée en stylo prérempli
A medicinal product containing exénatide, registered in France by ASTRAZENECA AB, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- EXÉNATIDE
- Manufacturer
- ASTRAZENECA AB
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009280120124 stylo prérempli en verre avec aiguille(s)EUR 76.58
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Exénatide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandBydureon 2 mg powder and solvent for prolonged-release suspension for injectionAstraZeneca AB
- United KingdomBydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pensAstraZeneca UK Ltd
- United StatesByettaAstraZeneca Pharmaceuticals LP
- FinlandBydureonAstraZeneca AB
- BelgiumBydureon 2 mgAstraZeneca
- SpainBYDUREON 2 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAstrazeneca Ab
- ItalyBYDUREON*4 penne preriempite Bcise SC 2 mg 0,85 ml rilascio prolungatoASTRAZENECA AB
- NorwayBydureonAstraZeneca
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad4752fe-d642-4a34-8918-42571d1adf91 GET /v1/drugs/ad4752fe-d642-4a34-8918-42571d1adf91?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66105532",
"date_amm": "2014-10-01",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/11/696",
"substance": "EXÉNATIDE",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre et solvant pour suspension injectable à libération prolongée",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about exénatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.